Cetera Advisor Networks LLC - XERIS BIOPHARMA HOLDINGS INC ownership

XERIS BIOPHARMA HOLDINGS INC's ticker is and the CUSIP is 98422E103. A total of 93 filers reported holding XERIS BIOPHARMA HOLDINGS INC in Q1 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.

Quarter-by-quarter ownership
Cetera Advisor Networks LLC ownership history of XERIS BIOPHARMA HOLDINGS INC
ValueSharesWeighting
Q3 2023$208,852
-28.1%
112,286
+1.3%
0.00%
-50.0%
Q2 2023$290,393
+70.9%
110,837
+6.3%
0.00%
+100.0%
Q1 2023$169,960
+51.5%
104,270
+23.6%
0.00%0.0%
Q4 2022$112,220
-15.0%
84,376
-0.1%
0.00%
-50.0%
Q3 2022$132,000
-27.1%
84,443
-28.1%
0.00%0.0%
Q2 2022$181,000
-23.0%
117,490
+28.2%
0.00%
-33.3%
Q1 2022$235,000
-6.0%
91,656
+7.4%
0.00%0.0%
Q4 2021$250,00085,3750.00%
Other shareholders
XERIS BIOPHARMA HOLDINGS INC shareholders Q1 2023
NameSharesValueWeighting ↓
CAXTON CORP 6,039,028$9,421,00017.72%
Stonepine Capital Management, LLC 12,928,168$20,168,0009.07%
SINECERA CAPITAL, LLC 253,101$395,0000.46%
NEA Management Company, LLC 3,246,785$5,065,0000.25%
DELTEC ASSET MANAGEMENT LLC 537,926$839,0000.21%
Kamunting Street Capital Management, L.P. 75,000$117,0000.19%
Alpine Global Management, LLC 400,000$624,0000.15%
ARMISTICE CAPITAL, LLC 2,504,431$3,907,0000.07%
Redmile Group, LLC 1,046,587$1,633,0000.06%
IHT Wealth Management, LLC 335,287$523,0000.04%
View complete list of XERIS BIOPHARMA HOLDINGS INC shareholders